ClinConnect ClinConnect Logo
Search / Trial NCT03011619

Brief CBT for the Treatment of Depression During Inpatient Hospitalization

Launched by NYU LANGONE HEALTH · Jan 4, 2017

Trial Information

Current as of July 22, 2025

Withdrawn

Keywords

Depression Cognitive Behavioral Therapy (Cbt)

ClinConnect Summary

Participants assigned to the CBT condition will receive the usual standard of care during an inpatient psychiatric hospitalization. This includes but is not limited to medication management, group therapy, and individual therapy. If a patient is randomly assigned to the enhanced CBT group, manualized CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.The training M.D., who is a treating physician on HCC-10, will also intermittently and randomly observe the CBT sessions to ensure the manual properly is being f...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed with depression according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria on initial assessment on the unit.
  • Demonstrates at least moderate degree of depressive symptoms on MADRS, HAM-D, and CGI-S.
  • Provides written informed consent.
  • Exclusion Criteria:
  • A mental illness other than depression that is the primary cause of treatment, as determined by the Principal Investigator.
  • A cognitive or neurologic disorder that inhibits ability to engage in CBT.

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Jacqueline Sergie, MD

Principal Investigator

NYU School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials